Employees: 03 (2023.0)Legal category: 5385Size: PMECreation date: 2009-07-15 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ANTIBES (06160), Alpes-Maritimes
SELAS PHARMACIE DE LA REGENCE : revenue, balance sheet and financial ratios
SELAS PHARMACIE DE LA REGENCE is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ANTIBES (06160),
this company of category PME
shows in 2022 a revenue of 2.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE DE LA REGENCE (SIREN 513708123)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue
N/C
N/C
2 256 924 €
2 141 496 €
1 975 830 €
1 982 943 €
N/C
N/C
N/C
1 940 412 €
Net income
65 886 €
36 953 €
134 338 €
142 390 €
98 308 €
-142 312 €
110 481 €
65 225 €
167 369 €
321 358 €
EBITDA
N/C
N/C
204 087 €
189 773 €
114 108 €
135 809 €
N/C
N/C
N/C
173 496 €
Net margin
N/C
N/C
6.0%
6.6%
5.0%
-7.2%
N/C
N/C
N/C
16.6%
Revenue and income statement
In 2024, SELAS PHARMACIE DE LA REGENCE generates positive net income of 66 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 321 k€ -> 66 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
65 886 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 76%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
76.479%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.554%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE DE LA REGENCE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
341.272
236.622
195.78
153.958
186.879
161.811
129.324
103.691
92.184
76.479
Financial autonomy
19.097
26.428
28.704
32.675
30.132
32.288
36.739
42.077
44.927
48.554
Repayment capacity
13.02
None
None
None
9.57
11.637
7.53
7.237
None
None
Cash flow / Revenue
5.828%
None%
None%
None%
6.201%
5.17%
6.975%
6.379%
None%
None%
Sector positioning
Debt ratio
76.482024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of SELAS PHARMACIE DE LA REG... (76.48) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.55%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of SELAS PHARMACIE DE LA REG... (48.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
7.24 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELAS PHARMACIE DE LA REG... (7.24) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 164.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
164.007
Liquidity indicators evolution SELAS PHARMACIE DE LA REGENCE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
77.036
97.996
88.32
90.708
121.875
145.247
166.729
185.176
179.348
164.007
Interest coverage
21.645
None
None
None
2.942
6.456
9.551
10.648
None
None
Sector positioning
Liquidity ratio
164.012024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average
In 2024, the liquidity ratio of SELAS PHARMACIE DE LA REG... (164.01) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
10.65x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of SELAS PHARMACIE DE LA REG... (10.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELAS PHARMACIE DE LA REGENCE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
160 996 €
0 €
0 €
0 €
299 841 €
366 339 €
260 941 €
298 072 €
0 €
0 €
Inventory turnover (days)
43
0
0
0
48
51
43
45
0
0
Customer payment term (days)
4
0
0
0
5
5
6
6
0
0
Supplier payment term (days)
54
0
0
0
53
61
61
54
0
0
Positioning of SELAS PHARMACIE DE LA REGENCE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELAS PHARMACIE DE LA REGENCE is estimated at
919 817 €
(range 640 546€ - 1 376 099€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
640k€919k€1376k€
919 817 €Range: 640 546€ - 1 376 099€
NAF 5 année 2024
Valuation method used
Net Income Multiple
65 886 €
×
14.0x
=919 817 €
Range: 640 546€ - 1 376 099€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE DE LA REGENCE with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE DE LA REGENCE
What is the revenue of SELAS PHARMACIE DE LA REGENCE ?
The revenue of SELAS PHARMACIE DE LA REGENCE in 2022 is 2.3 M€.
Is SELAS PHARMACIE DE LA REGENCE profitable?
Yes, SELAS PHARMACIE DE LA REGENCE generated a net profit of 66 k€ in 2024.
Where is the headquarters of SELAS PHARMACIE DE LA REGENCE ?
The headquarters of SELAS PHARMACIE DE LA REGENCE is located in ANTIBES (06160), in the department Alpes-Maritimes.
Where to find the tax return of SELAS PHARMACIE DE LA REGENCE ?
The tax return of SELAS PHARMACIE DE LA REGENCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE DE LA REGENCE operate?
SELAS PHARMACIE DE LA REGENCE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart